Stephen Friend

Stephen H. Friend is co-founder and director of Sage Bionetworks.[1][2][3]

Stephen Friend at NightScience 2013 in Paris

Formerly Senior Vice-President at Merck & Co. Friend co-founded Rosetta Inpharmatics with Leland H. Hartwell and Leroy Hood in 1996.[4] Much of his research has focused on cancer.[5]

Friend has also held faculty positions at Harvard Medical School and at Massachusetts General Hospital. He received his Bachelor of Arts in philosophy, his Ph.D. in biochemistry and his M.D. from Indiana University.[2]

Recognition

Friend is named an Ashoka Fellow by Ashoka: Innovators for the Public in 2011.[6]

Selected bibliography

References

  1. Kaiser, J. (2012). "The Visionary". Science. 335 (6069): 651–3. doi:10.1126/science.335.6069.651. PMID 22323794.
  2. "Sage Bionetworks Seattle | Directors". Archived from the original on 2012-01-27. Retrieved 2012-02-11.
  3. "Stephen Friend". Nature Reviews Drug Discovery. 7 (2): 114. 2008. doi:10.1038/nrd2509.
  4. Nelson, Bryn; Schadt, E (2009). "Something wiki this way comes". Nature. 458 (7234): 13. doi:10.1038/458013a. PMID 19262635.
  5. Kaiser, J. (2012). "The Visionary". Science. 335 (6069): 651–3. doi:10.1126/science.335.6069.651. PMID 22323794.
  6. http://sagebase.org/info/NewsInfoDownloads/SageAshokaRelease6APR2011.pdf%5B%5D
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.